Therefore, targeting the MUC4–Gal-3 interaction is a potential therapeutic strategy to prevent pancreatic cancer metastasis by inhibiting cancer cell adhesion to endothelial cells. Here, MUC4 is linked to familial pancreatic carcinoma.